Shanghai Haoxi Investment

The firm has not publicly named its investment committee or managing principals. As a corporate venture entity tied to Haoxi Health Technology Limited, deal decisions likely sit with senior executives of the parent company or a small internal investment team. No external biographies or leadership profiles have been disclosed in English-language public records.

It operates as a corporate investor, meaning its capital comes from the balance sheet of Haoxi Health Technology Limited rather than from a family or external limited partners. This structure makes it similar to a corporate venture capital (CVC) unit, where investment decisions are tied to the strategic interests of the parent operating company.

Available public record indicates a direct-investment posture across venture stages. There is no evidence of fund-of-fund commitments or allocations to external general partners. The firm appears to deploy capital directly into operating companies relevant to its parent's healthcare marketing ecosystem.

The firm spans the full venture spectrum — seed, start-up, and expansion through late-stage rounds. This range suggests both early-stage conviction bets and follow-on capacity for companies that reach commercial inflection points, though specific stage-concentration percentages are not public.

The capital is corporate balance-sheet equity from Haoxi Health Technology Limited, a Chinese company publicly listed on Nasdaq under the ticker HAIX. Haoxi Health provides online marketing solutions connecting healthcare providers with consumers, and its investment arm recycles operating cash flow and equity into venture-stage companies.